Akèy › Krèz
Etid klinik pou Krèz ap rekrite nan Etazini
56 etid pou Krèz ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC12 etid
- New York City, NY11 etid
- Philadelphia, PA10 etid
- Boston, MA8 etid
- Houston, TX7 etid
- Birmingham, AL7 etid
- Cincinnati, OH6 etid
- Dallas, TX6 etid
- Chicago, IL6 etid
- Durham, NC6 etid
- Aurora, CO5 etid
- Portland, OR5 etid
- San Francisco, CA5 etid
- Miami, FL5 etid
- Los Angeles, CA4 etid
- Columbus, OH4 etid
- Salt Lake City, UT4 etid
- Seattle, WA4 etid
- Charlotte, NC4 etid
- Orange, CA4 etid
- San Diego, CA4 etid
- Phoenix, AZ4 etid
- Orlando, FL4 etid
- Cleveland, OH4 etid
- Clifton, NJ4 etid
- Milwaukee, WI3 etid
- Ann Arbor, MI3 etid
- Atlanta, GA3 etid
- Nashville, TN3 etid
- Edison, NJ3 etid
- Detroit, MI3 etid
- Little Rock, AR3 etid
- Boise, ID3 etid
- Austin, TX3 etid
- Jacksonville, FL3 etid
- Rochester, MN3 etid
- New Haven, CT3 etid
- Mountain View, CA3 etid
Pa eta
- Alabama8 etid
- Arizona6 etid
- Arkansas4 etid
- Colorado6 etid
- Connecticut3 etid
- Florid16 etid
- Georgia3 etid
- Idaho3 etid
- Illinois7 etid
- Kalifòni15 etid
- Kentucky3 etid
- Maryland10 etid
- Massachusetts9 etid
- Michigan6 etid
- Minnesota4 etid
- Missouri4 etid
- New Jersey7 etid
- New York15 etid
- North Carolina10 etid
- Ohio12 etid
- Oregon5 etid
- Pennsylvania11 etid
- Tennessee5 etid
- Texas13 etid
- Utah5 etid
- Washington4 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Sep 28, 2026 · NCT02531880Modulating Movement Intention Via Cortical Stimulation
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT03233399Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07563881Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
Ap rekriteFaz 1 bonèMande peman pou patisipan yo
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07012148Natural History of Treated Neurocysticercosis and Long-Term Outcomes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 3 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT00001205Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
Ap rekrite
Laj 19 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT05784805Investigating Epilepsy: Screening and Evaluation
Ap rekriteEtid obsèvasyon
Laj 8 a 110 · Tout sèks · Mizajou Sep 21, 2026 · NCT03478852Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
Ap rekrite
Jiska laj 50 · Tout sèks · Mizajou Sep 17, 2026 · NCT02216500Prospective Natural History Study of POLG Disease
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 15, 2026 · NCT07775872An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Ap rekriteFaz 3
Laj 2 a 55 · Tout sèks · Mizajou Sep 15, 2026 · NCT05066217A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06388707A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04462770SeizEAR Safety Study
Ap rekriteVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088835Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07130786Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07594119Tumor Related Epilepsy
Ap rekriteEtid obsèvasyon
Laj 8 a 99 · Tout sèks · Mizajou Aug 28, 2026 · NCT02639325Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
Ap rekriteVolontè an sante akeyi
Laj 11 a 18 · Tout sèks · Mizajou Aug 26, 2026 · NCT05096273A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Aug 11, 2026 · NCT07233239Outcomes After Planned Discontinuation of AntiSeizure Medication
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07750496Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
Ap rekriteEtid obsèvasyon
Jiska laj 26 · Tout sèks · Mizajou Aug 6, 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Ap rekriteFaz 3
1 Day – 18 Years · Tout sèks · Mizajou Aug 3, 2026 · NCT07019922buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT05851391PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06401707Mapping of Human Cognition
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Jul 14, 2026 · NCT05989893Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
Ap rekriteFaz 1
0 Days – 9 Months · Tout sèks · Mizajou Jul 6, 2026 · NCT06700811Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.